SIMONINI, GABRIELE
 Distribuzione geografica
Continente #
NA - Nord America 12.152
EU - Europa 6.412
AS - Asia 1.659
AF - Africa 75
SA - Sud America 10
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 20.314
Nazione #
US - Stati Uniti d'America 12.099
RU - Federazione Russa 2.795
IE - Irlanda 938
IT - Italia 750
SE - Svezia 674
SG - Singapore 521
PL - Polonia 440
HK - Hong Kong 395
CN - Cina 324
IN - India 179
FI - Finlandia 178
DE - Germania 166
UA - Ucraina 125
GB - Regno Unito 102
JO - Giordania 91
TR - Turchia 82
ES - Italia 69
FR - Francia 63
CH - Svizzera 43
CA - Canada 39
CI - Costa d'Avorio 34
SC - Seychelles 28
AT - Austria 24
NL - Olanda 20
VN - Vietnam 18
IR - Iran 15
BE - Belgio 12
MX - Messico 12
KR - Corea 7
SA - Arabia Saudita 7
EG - Egitto 6
AU - Australia 5
CZ - Repubblica Ceca 5
IQ - Iraq 5
BR - Brasile 4
JP - Giappone 4
KZ - Kazakistan 4
MU - Mauritius 4
PE - Perù 4
ID - Indonesia 3
CL - Cile 2
EE - Estonia 2
ET - Etiopia 2
HR - Croazia 2
AZ - Azerbaigian 1
BH - Bahrain 1
CU - Cuba 1
EU - Europa 1
IM - Isola di Man 1
LT - Lituania 1
LV - Lettonia 1
MY - Malesia 1
PA - Panama 1
SI - Slovenia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 20.314
Città #
Santa Clara 3.292
Fairfield 1.250
Dublin 930
Chandler 888
Ashburn 642
Woodbridge 540
Cambridge 499
Seattle 494
Houston 455
Wilmington 446
Singapore 437
Warsaw 434
Lawrence 379
Altamura 373
Princeton 292
Ann Arbor 198
Jacksonville 195
Boston 193
Hong Kong 184
Moscow 132
Mumbai 126
Beijing 112
Medford 112
Buffalo 104
San Diego 94
Boardman 93
Izmir 81
New York 78
Shanghai 70
Florence 62
Barcelona 58
Falls Church 47
Kent 45
Bern 42
Milan 39
Norwalk 37
Pune 35
Abidjan 34
Hillsboro 29
Los Angeles 28
Toronto 26
Yubileyny 26
Vienna 24
Frankfurt Am Main 20
Salerno 18
Dong Ket 17
Andover 16
Guangzhou 16
Helsinki 16
London 14
Chennai 10
Nanjing 10
Brussels 9
Kilburn 9
Munich 9
Verona 9
Lappeenranta 8
West Jordan 8
Seoul 7
Tehran 7
Washington 7
Cairo 6
Dearborn 6
Naples 6
Philadelphia 6
A Coruña 5
Brno 5
Edmonton 5
Erbil 5
Khobar 5
Laurel 5
Padova 5
Phoenix 5
Prato 5
Rome 5
Rui'an 5
Trieste 5
Véry 5
Amsterdam 4
Canicattì 4
Düsseldorf 4
Frankfurt am Main 4
Lima 4
Menlo Park 4
Palermo 4
Pittsburgh 4
San Nicolás de los Garza 4
Serra 4
Turin 4
Akron 3
Auburn Hills 3
Bologna 3
Chengdu 3
Dongguan 3
Fiesole 3
Guadalupe 3
Hefei 3
Kish 3
Leuven 3
Montreal 3
Totale 14.031
Nome #
The intestinal microbiota in enthesitis-related arthitis 226
Alteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis. Associations with HLA-B27 Allele and Disease Status. 205
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-alpha therapy in childhood chronic uveitis. 185
Common symptoms for a rare disease in a girl with sarcoidosis: a case report 174
SAPHO syndrome in pediatric patients with inflammatory bowel disease treated with infliximab 168
Serum amyloid A circulating levels and disease activity in patients with juvenile idiopathic arthritis. 158
Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry. 149
Does switching anti-TNFα biologic agents represent an effective option in childhood chronic uveitis: The evidence from a systematic review and meta-analysis approach. 148
Immunosuppressive Activity of Abatacept on Circulating T Helper Lymphocytes from Juvenile Idiopathic Arthritis Patients 148
Serum osteopontin as a predictive marker of responsiveness to methotrexate in juvenile idiopathic arthritis. 147
Kawasaki disease: an epidemiological study in central Italy 147
Psoriatic juvenile idiopathic arthritis associated with uveitis: a case report. 145
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin. 143
Identification of autoantibodies against inner ear antigens in a cohort of children with idiopathic sensorineural hearing loss. 141
T cell subpopulations in juvenile idiopathic arthritis and their modifications after biotherapies 139
Describing Kawasaki shock syndrome: results from a retrospective study and literature review 139
Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium 138
Mycophenolate mofetil as induction and long-term maintaining treatment in childhood: Primary angiitis of the central nervous system 138
Anti-adalimumab antibodies in a cohort of patients with juvenile idiopathic arthritis: incidence and clinical correlations 137
Oxidative stress in Systemic Sclerosis. 127
Kawasaki disease in infants less than one year of age: An Italian cohort from a single center 127
Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis. 126
A peptide-based anti-Adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis 121
Osteoprotegerin serum levels in children with type 1 diabetes: a potential modulating role in bone status. 120
Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis. 120
Comparing ultraviolet light A photo(chemo)therapy with Methotrexate protocol in childhood localized scleroderma: Evidence from systematic review and meta-analysis approach 120
Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritis. 119
Flares after withdrawal of biologic therapies in juvenile idiopathic arthritis: Clinical and laboratory correlates of remission duration 118
Bone mass predictors in a large cohort of children with juvenile idiopathic arthritis (JIA) 118
Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach. 117
The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: Our experience and review of the literature. 115
Glucocorticoids in the management of systemic juvenile idiopathic arthritis. 115
Joint pain management in children and adolescents 113
Early predictors of juvenile sacroiliitis in enthesitis-related arthritis. 113
Sequential MR angiography in childhood primary angiitis of the CNS. 113
The common NOD2/CARD15 variant P268S in patients with non-infectious uveitis: a cohort study 112
Lack of association between the HLA-DRB1 locus and post-streptococcal reactive arthritis and acute rheumatic fever in italian children 111
Coeliac disease in patients with Kawasaki disease. Is there a link? 110
Macrophage activation syndrome/Hemophagocytic Lymphohistiocytosis and Kawasaki disease. 110
Erratum to: Successful treatment with adalimumab for severe multifocal choroiditis and panuveitis in presumed (early-onset) ocular sarcoidosis 109
Clinical features and outcome of Cogan syndrome. 109
Anticorpi anti-istone: È sempre lupus indotto da farmaci? 108
Pediatric Osteoporosis: Diagnosis and Treatment Considerations 108
Loss of efficacy during long-term infliximab therapy for sight-threatening childhood uveitis. 108
Successful treatment with canakinumab of a paediatric patient with resistant Behçet's disease 108
Systemic-onset juvenile idiopathic arthritis complicated by early onset amyloidosis in a patient carrying a mutation in the MEFV gene. 107
Changing evidence over time: Updated meta-analysis regarding anti-TNF efficacy in childhood chronic uveitis 106
Surface plasmon resonance-based methodology for anti-adalimumab antibody identification and kinetic characterization 106
Bone status over one-year etanercept treatment in juvenile idiopathic arthritis 105
Thyroid function, autoimmune thyroiditis and coeliac disease in juvenile idiopathic arthritis 105
Recent advances in the use of Anti-TNFα therapy for the treatment of juvenile idiopathic arthritis 105
Childhood uveitis 104
Diene-conjugates and antibodies against oxidized low-density lipoproteins in systemic sclerosis. 104
Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis 103
Circulating leptin levels in juvenile idiopathic arthritis: a marker of nutritional status? 102
Severe cutaneous manifestations in a child with refractory Kawasaki disease. 101
Anakinra treatment in drug-resistant Behcet's disease: a case series. 100
Switching from Reference to Biosimilars Does Not Reduce Efficacy and Safety in Juvenile Idiopathic Arthritis 99
Bcl-2, p53 and c-myc expression in juvenile dermatomyositis. 98
Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): State of the art and future perspectives. 98
Utility of magnetic resonance imaging when following up sacroiliitis in enthesitis-related arthritis. 98
Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis. 98
Acute febrile cholestasis as inaugural manifestation of Kawasaki’s disease. 97
Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. 96
Early anti IL-1 treatment replaces steroids in refractory Kawasaki disease: clinical experience from two case reports 96
Common variable immunodeficiency presenting as sarcoidosis in a 9-year-old child 96
OBSIDIAn - real world evidence of Originator to BioSImilar Drug switch in juvenile idiopathic arthritis 95
Temporomandibular Joint Involvement and Quality Of Life In Juvenile Idiopathic Arthritis 95
Sustained improvement of a girl affected with Devic’sdisease over 2 years of mycophenolate mofetil treatment 94
Fast recovery of cardiac function in PIMS-TS patients early using intravenous anti-IL-1 treatment 93
Treatment strategies for childhood noninfectious chronic uveitis: an update. 91
Surgical abdomen with intestinal pseudo-obstruction as presenting feature of atypical Kawasaki disease. 91
The Development of Extra-Articular Manifestations in Children With Enthesitis-Related Arthritis: Natural Course or Different Disease Entity? 91
Diagnostic challenge of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome in pediatric age: A monocentric case series 90
Cervical arthritis as early manifestation of enthesitis-related arthritis complicated by uveitis 90
Osteomielite cronica ricorrente in età pediatrica 89
The off-label use of anakinra in pediatric systemic autoinflammatory diseases 89
Development and preliminary validation of a diagnostic score for identifying patients affected with adult-onset autoinflammatory disorders. 88
Long-term follow-up of coronary artery lesions in children in Kawasaki syndrome 88
Association of low bone mass with vitamin d receptor gene and calcitonin receptor gene polymorphisms in juvenile idiopathic arthritis. 88
Usefulness of wireless capsule endoscopy for detecting inflammatory bowel disease in children presenting with arthropathy. 88
Bone status evaluation with calcaneal ultrasound in children with chronic rheumatic diseases. A one year followup study. 88
Retinal capillaritis in a CRB1-associated retinal dystrophy 88
Bilateral renal artery stenosis in Kawasaki disease: a report of two cases. 87
CD4+CD161+cells with Th1 or Th17/Th1 profile accumulate in the synovial fluid of patients with oligo- and polyarticular juvenile idiopathic arthritis 87
Prebiologic Therapy Tuberculosis Screening Experience in a Pediatric Rheumatology Center: TST and IGRA Are Both Necessary 87
Long-term efficacy of abatacept in pediatric patients with idiopathic uveitis: a case series 87
Evidence of immune activation against oxidized lipoproteins in inactive phases of juvenile chronic arthritis. 87
Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension. 86
Craniofacial morphology in a cohort of juvenile idiopathic arthritis children. 86
The conundrum of juvenile spondyloarthritis classification: Many names for a single disease? Lesson learned from an instructive clinical case 86
Idiopathic calcinosis in a paediatric patient 86
CANAKINUMAB IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: REAL-LIFE DATA FROM A RETROSPECTIVE ITALIAN COHORT 86
Cutaneous polyarteritis nodosa and common variable immunodeficiency: a previously unreported association. 86
Long-Term Efficacy and Safety of Mycophenolate Mofetil in Childhood Primary Central Nervous System Vasculitis 86
Flares after Withdrawal of Biotherapies in JIA: Clinical and Laboratory Correlates of Remission Duration 86
Diagnosing Kawasaki syndrome: the need for a new clinical tool. 85
AB1025 Chronic Recurrent Multifocal Osteomyelitis (CRMO): The Importance of an Accurate Differential Diagnosis 85
INTESTINAL PSEUDO-OBSTRUCTION: A TRICKY DIAGNOSIS OF ATYPICAL KAWASAKI DISEASE 85
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis. 85
Totale 11.093
Categoria #
all - tutte 66.723
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.723


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.381 0 0 0 0 0 269 258 270 241 142 157 44
2020/20211.256 108 107 69 161 46 132 45 112 101 182 87 106
2021/20221.744 42 222 196 110 35 51 61 156 47 39 271 514
2022/20234.214 421 957 173 270 278 752 523 201 381 31 140 87
2023/20241.523 60 176 277 87 103 265 66 254 42 79 84 30
2024/20257.549 392 1.089 588 1.541 2.993 946 0 0 0 0 0 0
Totale 20.641